Effect of Compound 21-A Selective Angiotensin II Type 2 Receptor Agonist in an Abdominal Adhesion Murine Model

被引：0
|
作者：
Boudreau, C. G. [1 ]
Levatte, T. [1 ]
Gareau, A. [2 ]
Legere, S. [1 ]
Bezuhly, M. [3 ]
机构：
[1] Dalhousie Univ, Med, Halifax, NS, Canada
[2] Calgary Lab Serv, Calgary, AB, Canada
[3] Dalhousie Univ, Dept Plast Surg, Halifax, NS, Canada
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P317
引用
收藏
页码：S171 / S171
页数：1
相关论文
共 50 条
  • [1] Effect of Compound 21, a Selective Angiotensin II Type 2 Receptor Agonist, in a Murine Xenograft Model of Dupuytren Disease
    Chisholm, Jessica
    Gareau, Alison J.
    Byun, Stephanie
    Paletz, Justin L.
    Tang, David
    Williams, Jason
    LeVatte, Terry
    Bezuhly, Michael
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 140 (05) : 686E - 696E
  • [2] The Selective Angiotensin II Type 2 Receptor Agonist Compound 21 Reduces Abdominal Adhesions in Mice
    Boudreau, Colton
    LeVatte, Terry
    Jones, Courtney
    Gareau, Alison
    Legere, Stephanie
    Bezuhly, Michael
    JOURNAL OF SURGICAL RESEARCH, 2020, 256 : 231 - 242
  • [3] The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome
    Verbrugghe, Peter
    Verhoeven, Jelle
    Clijsters, Marnick
    Vervoort, Dominique
    Schepens, Jarne
    Meuris, Bart
    Herijgers, Paul
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2018, 71 (04) : 215 - 222
  • [4] Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
    Menk, Mario
    Graw, Jan Adriaan
    von Haefen, Clarissa
    Steinkraus, Hendrik
    Lachmann, Burkhard
    Spies, Claudia D.
    Schwaiberger, David
    JOURNAL OF INFLAMMATION RESEARCH, 2018, 11 : 169 - 178
  • [5] Intrarenal Angiotensin Type 2 Receptor Stimulation with Selective Nonpeptide Agonist Compound 21 Induces Natriuresis in Rats
    Padia, Shetal H.
    Kemp, Brandon A.
    Howell, Nancy L.
    Carey, Robert M.
    HYPERTENSION, 2009, 54 (04) : E79 - E79
  • [6] The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis
    Bryna S. M. Chow
    Christine Koulis
    Pooja Krishnaswamy
    Ulrike M. Steckelings
    Thomas Unger
    Mark E. Cooper
    Karin A. Jandeleit-Dahm
    Terri J. Allen
    Diabetologia, 2016, 59 : 1778 - 1790
  • [7] The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis
    Chow, Bryna S. M.
    Koulis, Christine
    Krishnaswamy, Pooja
    Steckelings, Ulrike M.
    Unger, Thomas
    Cooper, Mark E.
    Jandeleit-Dahm, Karin A.
    Allen, Terri J.
    DIABETOLOGIA, 2016, 59 (08) : 1778 - 1790
  • [8] Compound 21, an angiotensin II type 2 receptor agonist, is protective in experimental diabetes-associated atherosclerosis
    Allen, T.
    Koulis, C.
    Steckelings, U.
    Unger, T.
    Jandeleit-Dahm, K.
    Cooper, M.
    Chow, B. S. M.
    DIABETOLOGIA, 2016, 59 : S115 - S115
  • [9] The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury
    Rathinasabapathy, Anandharajan
    Horowitz, Alana
    Horton, Kelsey
    Kumar, Ashok
    Gladson, Santhi
    Unger, Thomas
    Martinez, Diana
    Bedse, Gaurav
    West, James
    Raizada, Mohan K.
    Steckelings, Ulrike M.
    Sumners, Colin
    Katovich, Michael J.
    Shenoy, Vinayak
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [10] Why Do We Need a Selective Angiotensin II Type 2 Receptor Agonist?
    Henrion, Daniel
    HYPERTENSION, 2012, 60 (03) : 616 - 617
12345